Latest update:
Thursday, March 2, 2017 - 18:21
Тhe European Commission (EC) and the US Food and Drug Administration have reached an agreement which will enable EU and FDA to avoid the duplication of inspections of medicines manufacturing facilities in the two regions.
The EU Member States' authorities will recognise inspections made by US authorities, and vice versa.
for more information: